What is Simulations Plus's discovery — revenue?

Simulations Plus (SLP) reported discovery — revenue of $2.73M in Q4 2025.

What does discovery — revenue mean?

This metric represents the total revenue generated specifically from the Discovery segment, which focuses on software and consulting services for early-stage pharmaceutical research. It serves as a key indicator of the company's ability to monetize its specialized research tools and expertise within the drug discovery pipeline. Growth in this segment reflects successful market adoption of discovery-phase solutions and the expansion of the client base in the preclinical research market.

Simulations Plus SLP Discovery — Revenue

Similar metrics at other companies

SDGRDrug discovery — Total revenues

$22.88M+124%

SDGRDrug Discovery Services — Drug discovery services revenue from contracts with customers

$11.7M+105%

SDGRDrug discovery contribution — Total revenues

$148K-70.3%

SDGRDrug discovery — Drug discovery services revenue from contracts with customers

$23.03M+115%

SDGRDrug discovery — Revenue recognized with milestones

$0-100%

SDGRRevenue from contracts with customers — Drug discovery services revenue from contracts with customers

$45.88M+6.5%

Other financials

Income statement

See full

Revenue$24.3M+8.3%

Gross profit$16.1M+23.0%

Operating income$5.6M+108%

Net income$4.5M+47.5%

EPS (diluted)$0.22+46.7%

Balance sheet

See full

Cash & equivalents$25.7M+134%

Total debt$508.0K-36.2%

Total equity$133.8M-29.4%

Total assets$146.5M-27.3%

Cash flow

See full

Operating cash flow$6.4M+13.1%

CapEx$46.0K-30.3%

Free cash flow$6.4M+13.6%

Valuation

See full

Market cap$366.73M+5.2%

Enterprise value$341.51M+6.0%

P/S4.6×+0.2×

Profitability

See full

Gross margin62%+6.7pp

Operating margin-84.3%—

Net margin-78%-87.2pp

FCF margin29.5%+14.9pp

Returns & leverage

See full

Return on equity-38.8%-42.8pp

Debt / equity0×0.0×

Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's discovery — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Simulations Plus's discovery — revenue?: Simulations Plus (SLP) reported discovery — revenue of $2.73M in Q4 2025.
What does discovery — revenue mean?: This metric represents the total revenue generated specifically from the Discovery segment, which focuses on software and consulting services for early-stage pharmaceutical research. It serves as a key indicator of the company's ability to monetize its specialized research tools and expertise within the drug discovery pipeline. Growth in this segment reflects successful market adoption of discovery-phase solutions and the expansion of the client base in the preclinical research market.